Literature DB >> 29107739

Comparative restoration of acute liver failure by menstrual blood stem cells compared with bone marrow stem cells in mice model.

Mina Fathi-Kazerooni1, Gholamreza Tavoosidana1, Masoud Taghizadeh-Jahed2, Sayeh Khanjani2, Hananeh Golshahi3, Caroline E Gargett4, Haleh Edalatkhah2, Somaieh Kazemnejad5.   

Abstract

BACKGROUND AIMS: The application of menstrual blood stem cells (MenSCs) in regenerative medicine is gaining increasing attention. The aim of this study was to investigate the therapeutic potential of MenSCs compared with bone marrow-derived stem cells (BMSCs) in an animal model of CCl4-induced acute hepatic failure.
METHODS: Injured Balb/C mice were divided into multiple groups and received MenSCs, BMSCs or hepatocyte progenitor-like (HPL) cells derived from these cells.
RESULTS: Tracking of green fluorescent protein-labeled cells showed homing of cells in injured areas of the liver. In addition, the liver engraftment of MenSCs was shown by immunofluorescence staining using anti-human mitochondrial antibody. Microscopically examination, periodic acid-Schiff and Masson's trichrome staining of liver sections demonstrated the considerable liver regeneration post-cell therapy in all groups. Assessment of serum parameters including aspartate aminotransferase, alanine aminotransferase, total bilirubin, urea and cholesterol at day 7 exhibited significant reduction, such that this downward trend continued significantly until day 30. The restoration of liver biochemical markers, changes in mRNA levels of hepatic markers and the suppression of inflammatory markers were more significant in the MenSC-treated group compared with the BMSC-treated group. On the other hand, HPL cells in reference to undifferentiated cells had better effectiveness in the treatment of the acute liver injury.
CONCLUSIONS: Our data show that MenSCs may be considered an appropriate alternative stem cell population to BMSCs for treatment of acute liver failure.
Copyright © 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bone marrow stem cells; liver injury; menstrual blood stem cells; regenerative medicine

Mesh:

Substances:

Year:  2017        PMID: 29107739     DOI: 10.1016/j.jcyt.2017.08.022

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  13 in total

Review 1.  Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases.

Authors:  Yanli Liu; Rongcheng Niu; Wenzhong Li; Juntang Lin; Christof Stamm; Gustav Steinhoff; Nan Ma
Journal:  Cell Mol Life Sci       Date:  2019-02-05       Impact factor: 9.261

2.  IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection.

Authors:  Hong Qin; Chenglu Sun; Yanglin Zhu; Yafei Qin; Shaohua Ren; Zhaobo Wang; Chuan Li; Xiang Li; Baoren Zhang; Jingpeng Hao; Guangming Li; Hongda Wang; Bo Shao; Jingyi Zhang; Hao Wang
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

3.  Platelet-rich plasma improves therapeutic effects of menstrual blood-derived stromal cells in rat model of intrauterine adhesion.

Authors:  Siwen Zhang; Pingping Li; Zhengwei Yuan; Jichun Tan
Journal:  Stem Cell Res Ther       Date:  2019-02-15       Impact factor: 6.832

4.  Therapeutic potential of menstrual blood stem cells in treating acute liver failure.

Authors:  Pan-Pan Cen; Lin-Xiao Fan; Jie Wang; Jia-Jia Chen; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2019-11-07       Impact factor: 5.742

5.  Menstrual blood-derived stromal cells modulate functional properties of mouse and human macrophages.

Authors:  Rocío Martínez-Aguilar; Salvador Romero-Pinedo; M José Ruiz-Magaña; Enrique G Olivares; Carmen Ruiz-Ruiz; Ana C Abadía-Molina
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

Review 6.  Understanding menstrual blood-derived stromal/stem cells: Definition and properties. Are we rushing into their therapeutic applications?

Authors:  Alicia Sanchez-Mata; Elena Gonzalez-Muñoz
Journal:  iScience       Date:  2021-11-22

7.  Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice.

Authors:  Youkun Bi; Xuejun Guo; Mengqi Zhang; Keqi Zhu; Chentao Shi; Baoqi Fan; Yanyun Wu; Zhiguang Yang; Guangju Ji
Journal:  Stem Cell Res Ther       Date:  2021-12-11       Impact factor: 6.832

8.  The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration.

Authors:  Jimena Cuenca; Alice Le-Gatt; Valentina Castillo; Jose Belletti; Macarena Díaz; Mónica Kurte G; Paz L Gonzalez; Francisca Alcayaga-Miranda; Christina M A P Schuh; Fernando Ezquer; Marcelo Ezquer; Maroun Khoury
Journal:  Front Physiol       Date:  2018-05-14       Impact factor: 4.566

9.  Menstrual Blood Stem Cell Transplantation in Mice Model of Acute Liver Failure: Does Gender of Recipient Affect the Outcome?

Authors:  Mina Fathi-Kazerooni; Gholamreza Tavoosidana
Journal:  Avicenna J Med Biotechnol       Date:  2019 Oct-Dec

10.  Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis.

Authors:  Yanli Liu; Shengying Liang; Fen Yang; Yuliang Sun; Lidan Niu; Yakun Ren; Hongmei Wang; Yanan He; Jiang Du; Jun Yang; Juntang Lin
Journal:  Stem Cell Res Ther       Date:  2020-08-08       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.